ResearcherShandong UniversityNo recent work listed

Baoyou Sun

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5075894895. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 2 papers

Papers 2

The small-molecule IAP antagonist AT406 inhibits pancreatic cancer cells in vitro and in vivo. Last author DOI 10.1016/j.bbrc.2016.07.011 ↗
Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity. First author DOI 10.1016/j.bbrc.2016.08.121 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qing Zhang · 1 shared paper, 2016 · strength 0.08
- Paper Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity. DOI 10.1016/j.bbrc.2016.08.121 ↗
Jingjing Zhang · 1 shared paper, 2016 · strength 0.08
- Paper Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity. DOI 10.1016/j.bbrc.2016.08.121 ↗
Xiaoguang Zhao · 1 shared paper, 2016 · strength 0.08
- Paper Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity. DOI 10.1016/j.bbrc.2016.08.121 ↗
Bo Chen · 1 shared paper, 2016 · strength 0.07
- Paper The small-molecule IAP antagonist AT406 inhibits pancreatic cancer cells in vitro and in vivo. DOI 10.1016/j.bbrc.2016.07.011 ↗
Yongsheng Jiang · 1 shared paper, 2016 · strength 0.07
- Paper The small-molecule IAP antagonist AT406 inhibits pancreatic cancer cells in vitro and in vivo. DOI 10.1016/j.bbrc.2016.07.011 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.